Sigma-Tau Finanziaria

Showing 1 posts of 1 posts found.

Baxter buys cancer portfolio for $900 million

May 13, 2015
Research and Development, Sales and Marketing Cancer, Oncaspar, Sigma-Tau Finanziaria, baxter, oncology

Baxter is buying leukaemia treatment Oncaspar from Italian firm Sigma-Tau Finanziaria for $900 million as the US firm looks to …

The Gateway to Local Adoption Series

Latest content